* Inspire Medical Systems Inc INSP.N INSP.K is expected
to show a rise in quarterly revenue when it reports results on
November 7.
* The Golden Valley Minnesota-based company is expected to
report
a 41.5% increase in revenue to $154.451 million from $109.19
million a year ago, according to the mean estimate from 13
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for Inspire Medical
Systems
Inc is for a loss of 58 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Inspire
Medical
Systems Inc is $280, above its last closing price of $169.70.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.54 -0.57 -0.41 Beat 28
Mar. 31 2023 -0.67 -0.66 -0.53 Beat 19.7
Dec. 31 2022 -0.48 -0.57 0.10 Beat 117.7
Sep. 30 2022 -0.74 -0.77 -0.60 Beat 21.7
Jun. -0.61 -0.62 -0.53 Beat 14.3
30 2022
Mar. 31 2022 -0.75 -0.80 -0.61 Beat 23.4
Dec. 31 2021 -0.41 -0.44 -0.09 Beat 79.4
Sep. 30 2021 -0.60 -0.61 -0.38 Beat 38.2
This summary was machine generated November 4 at 01:23 GMT. All
figures in US dollars unless otherwise stated